Infliximab Concentrations in Participants with Moderate to Severe COVID-19

被引：1
|
作者：
Balevic, Stephen J. [1 ,2 ,8 ,9 ]
Dandachi, Dima [3 ]
Dixon, Danielle [4 ]
Hoetelmans, Richard M. W. [5 ]
Bozzette, Sam [6 ]
Mccarthy, Matthew W. [7 ]
机构：
[1] Duke Univ, Sch Med, Dept Med, Durham, NC USA
[2] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[3] Univ Missouri Columbia, Columbia, MO USA
[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
[5] Janssen Infect Dis BVBA, Beerse, Belgium
[6] Natl Ctr Advancing Translat Sci, Bethesda, MD USA
[7] Weill Cornell Med, New York, NY USA
[8] Duke Univ, Dept Med, Sch Med, 2301 Erwin Rd,T0909, Durham, NC 27710 USA
[9] Duke Univ, Dept Pediat, Sch Med, 2301 Erwin Rd,T0909, Durham, NC 27710 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 64卷 / 04期
关键词：
COVID-19; infliximab; pharmacokinetics;
D O I：
10.1002/jcph.2388
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：490 / 491
页数：2
相关论文
共 50 条
  • [21] Infliximab as a potential treatment for COVID-19
    Velez, Matthew P.
    McCarthy, Matthew W.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (01) : 1 - 5
  • [22] Olfactory Dysfunction in Mild-Moderate-Severe COVID-19 Patients
    Tuzun, Kemal
    Abes, Derya
    [J]. B-ENT, 2022, 18 (01) : 59 - 66
  • [23] Surgical complications in COVID-19 patients in the setting of moderate to severe disease
    Gulinac, Milena
    Novakov, Ivan P.
    Antovic, Svetozar
    Velikova, Tsvetelina
    [J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 13 (08): : 788 - 795
  • [24] Altered platelet and coagulation function in moderate-to-severe COVID-19
    Litvinov, Rustem I.
    Evtugina, Natalia G.
    Peshkova, Alina D.
    Safiullina, Svetlana I.
    Andrianova, Izabella A.
    Khabirova, Alina I.
    Nagaswami, Chandrasekaran
    Khismatullin, Rafael R.
    Sannikova, Svetlana S.
    Weisel, John W.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (09) : 1117 - 1117
  • [26] Targeted Advanced Home Care for Patients With Moderate or Severe COVID-19
    Kato, Koki
    Nakagawa, Takafumi
    [J]. ANNALS OF FAMILY MEDICINE, 2022, 20 (01) : 91 - 91
  • [27] Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Lewis-Wolfson, Temeka Dawn
    Joyner, Kayla Rena
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (09) : 1118 - 1119
  • [28] Asymptomatic olfactory dysfunction in nonintubated patients with moderate and severe COVID-19
    Mata-Mendoza, Patricia
    Delgado-Garcia, Guillermo
    Gonzalez-Munoz, Alejandro
    Antonio Fernandez-Vera, Jose
    [J]. NEUROLOGY, 2021, 96 (15)
  • [29] Prevalence and impact of comorbidities in Tunisian moderate to severe COVID-19 patients
    Kaabi, Line
    Louhaichi, Sabrine
    Khalfallah, Ikbel
    Jebali, Rihab
    Marzouki, Safa
    Kharrat, Med Ali
    Ammar, Jamel
    Hamzaoui, Agnes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Cautious handling of urine from moderate to severe COVID-19 patients
    Nomoto, Hidetoshi
    Ishikane, Masahiro
    Katagiri, Daisuke
    Kinoshita, Noriko
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Ohmagari, Norio
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2020, 48 (08) : 969 - 971
12345